{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:15:05Z","timestamp":1791472505179,"version":"4.3.4"},"reference-count":66,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["LP150100419"],"award-info":[{"award-number":["LP150100419"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1164475"],"award-info":[{"award-number":["APP1164475"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Diabetes Society of South Australia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Glucagon is secreted by pancreatic \u03b1 cells in response to hypoglycemia and increases hepatic glucose output through hepatic glucagon receptors (GCGRs). There is evidence supporting the notion of extrapancreatic glucagon but its source and physiological functions remain elusive. Intestinal tissue samples were obtained from patients undergoing surgical resection of cancer. Mass spectrometry analysis was used to detect glucagon from mucosal lysate. Static incubations of mucosal tissue were performed to assess glucagon secretory response. Glucagon concentration was quantitated using a highly specific sandwich enzyme-linked immunosorbent assay. A cholesterol uptake assay and an isolated murine colonic motility assay were used to assess the physiological functions of intestinal GCGRs. Fully processed glucagon was detected by mass spectrometry in human intestinal mucosal lysate. High glucose evoked significant glucagon secretion from human ileal tissue independent of sodium glucose cotransporter and KATP channels, contrasting glucose-induced glucagon-like peptide 1 (GLP-1) secretion. The GLP-1 receptor agonist Exendin-4 attenuated glucose-induced glucagon secretion from the human ileum. GCGR blockade significantly increased cholesterol uptake in human ileal crypt culture and markedly slowed ex vivo colonic motility. Our findings describe the human gut as a potential source of extrapancreatic glucagon and demonstrate a novel enteric glucagon\/GCGR circuit with important physiological functions beyond glycemic regulation.<\/jats:p>","DOI":"10.1210\/endocr\/bqab022","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T01:13:39Z","timestamp":1612660419000},"source":"Crossref","is-referenced-by-count":13,"title":["Evidence for Glucagon Secretion and Function Within the Human Gut"],"prefix":"10.1210","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-918X","authenticated-orcid":false,"given":"Emily W","family":"Sun","sequence":"first","affiliation":[{"name":"Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-8307","authenticated-orcid":false,"given":"Alyce M","family":"Martin","sequence":"additional","affiliation":[{"name":"Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayan","family":"de Fontgalland","sequence":"additional","affiliation":[{"name":"Department of Surgery, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Sposato","sequence":"additional","affiliation":[{"name":"Department of Surgery, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Rabbitt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-0060","authenticated-orcid":false,"given":"Paul","family":"Hollington","sequence":"additional","affiliation":[{"name":"Department of Surgery, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Wattchow","sequence":"additional","affiliation":[{"name":"Department of Surgery, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D","family":"Colella","sequence":"additional","affiliation":[{"name":"Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0254-8099","authenticated-orcid":false,"given":"Tim","family":"Chataway","sequence":"additional","affiliation":[{"name":"Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-5753","authenticated-orcid":false,"given":"Nicolai J","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J","family":"Spencer","sequence":"additional","affiliation":[{"name":"Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5116-4951","authenticated-orcid":false,"given":"Richard L","family":"Young","sequence":"additional","affiliation":[{"name":"Adelaide Medical School and NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, SA, Australia"},{"name":"Nutrition, Diabetes and Metabolism, Lifelong Health, South Australia Health and Medical Research Institute, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-8305","authenticated-orcid":false,"given":"Damien J","family":"Keating","sequence":"additional","affiliation":[{"name":"Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"issue":"3","key":"2021121713225441600_CIT0001","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/er.2006-0026","article-title":"The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications","volume":"28","author":"Dunning","year":"2007","journal-title":"Endocr Rev."},{"issue":"4","key":"2021121713225441600_CIT0002","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00125-006-0566-z","article-title":"Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus","volume":"50","author":"Knop","year":"2007","journal-title":"Diabetologia."},{"issue":"4","key":"2021121713225441600_CIT0003","doi-asserted-by":"crossref","first-page":"E832","DOI":"10.1152\/ajpendo.00700.2009","article-title":"Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes","volume":"298","author":"Hare","year":"2010","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"4","key":"2021121713225441600_CIT0004","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/dom.12446","article-title":"Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes","volume":"17","author":"Kelly","year":"2015","journal-title":"Diabetes Obes Metab."},{"issue":"5","key":"2021121713225441600_CIT0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF00282517","article-title":"Circulating glucagon after total pancreatectomy in man","volume":"25","author":"Holst","year":"1983","journal-title":"Diabetologia."},{"issue":"10","key":"2021121713225441600_CIT0006","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2337\/diab.30.10.851","article-title":"Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human","volume":"30","author":"Bringer","year":"1981","journal-title":"Diabetes."},{"issue":"5","key":"2021121713225441600_CIT0007","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.soard.2018.01.039","article-title":"Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery","volume":"14","author":"Roberts","year":"2018","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"2021121713225441600_CIT0008","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/EJE-13-0941","article-title":"Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans","volume":"170","author":"Bak","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2021121713225441600_CIT0009","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2337\/db15-1541","article-title":"Evidence of extrapancreatic glucagon secretion in man","volume":"65","author":"Lund","year":"2016","journal-title":"Diabetes."},{"issue":"12","key":"2021121713225441600_CIT0010","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1210\/jc.2019-00062","article-title":"Investigating intestinal glucagon after Roux-en-Y gastric bypass surgery","volume":"104","author":"Jorsal","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021121713225441600_CIT0011","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s00125-014-3264-2","article-title":"Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals","volume":"57","author":"Bagger","year":"2014","journal-title":"Diabetologia."},{"issue":"11","key":"2021121713225441600_CIT0012","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1210\/jc.2016-1948","article-title":"Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion","volume":"101","author":"Lund","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2021121713225441600_CIT0013","article-title":"Data from: Gut-derived glucagon in human","author":"Sun","journal-title":"Figshare. Deposited November 19, 2020."},{"key":"2021121713225441600_CIT0014"},{"key":"2021121713225441600_CIT0015","author":"Mercodia Glicentin ELISA kit"},{"key":"2021121713225441600_CIT0016","author":"Merck Millipore active GLP-1 ELISA"},{"key":"2021121713225441600_CIT0017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2016.03.034","article-title":"Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma","volume":"7","author":"Wewer Albrechtsen","year":"2016","journal-title":"Ebiomedicine."},{"key":"2021121713225441600_CIT0018","first-page":"52483","article-title":"Establishment of human epithelial enteroids and colonoids from whole tissue and biopsy","author":"Mahe","year":"2015","journal-title":"J Vis Exp"},{"key":"2021121713225441600_CIT0019","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fnins.2014.00096","article-title":"Control of intrinsic pacemaker frequency and velocity of colonic migrating motor complexes in mouse","volume":"8","author":"Barnes","year":"2014","journal-title":"Front Neurosci."},{"issue":"23","key":"2021121713225441600_CIT0020","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.4155\/bio.13.264","article-title":"Sensitive glucagon quantification by immunochemical and LC-MS\/MS methods","volume":"5","author":"Lapko","year":"2013","journal-title":"Bioanalysis."},{"issue":"6","key":"2021121713225441600_CIT0021","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.celrep.2017.10.034","article-title":"circulating glucagon 1-61 regulates blood glucose by increasing insulin secretion and hepatic glucose production","volume":"21","author":"Wewer Albrechtsen","year":"2017","journal-title":"Cell Rep."},{"key":"2021121713225441600_CIT0022","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmet.2019.10.003","article-title":"The challenge of correctly reporting hormones content and secretion in isolated human islets","volume":"30","author":"Henquin","year":"2019","journal-title":"Mol Metab."},{"key":"2021121713225441600_CIT0023","doi-asserted-by":"crossref","first-page":"e001076","DOI":"10.1136\/bmjdrc-2019-001076","article-title":"Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study","volume":"8(1)","author":"Alexiadou","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2021121713225441600_CIT0024","article-title":"Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes","volume":"3(23)","author":"Bahne","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"2021121713225441600_CIT0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2337\/db14-0807","article-title":"Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine","volume":"64","author":"Kuhre","year":"2015","journal-title":"Diabetes."},{"issue":"8","key":"2021121713225441600_CIT0026","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.2337\/db17-0058","article-title":"Mechanisms controlling glucose-induced GLP-1 secretion in human small intestine","volume":"66","author":"Sun","year":"2017","journal-title":"Diabetes."},{"key":"2021121713225441600_CIT0027","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3389\/fendo.2018.00741","article-title":"Gut mechanisms linking intestinal sweet sensing to glycemic control","volume":"9","author":"Kreuch","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"2021121713225441600_CIT0028","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41467-018-04353-y","article-title":"LRRC8\/VRAC anion channels enhance \u03b2-cell glucose sensing and insulin secretion","volume":"9","author":"Stuhlmann","year":"2018","journal-title":"Nat Commun."},{"issue":"7","key":"2021121713225441600_CIT0029","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.bjp.0704413","article-title":"DCPIB is a novel selective blocker of I(Cl,swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration","volume":"134","author":"Decher","year":"2001","journal-title":"Br J Pharmacol."},{"issue":"5","key":"2021121713225441600_CIT0030","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2337\/diab.36.5.592","article-title":"Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia","volume":"36","author":"Klaff","year":"1987","journal-title":"Diabetes."},{"issue":"7","key":"2021121713225441600_CIT0031","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2337\/diab.38.7.902","article-title":"Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide","volume":"38","author":"Komatsu","year":"1989","journal-title":"Diabetes."},{"issue":"19","key":"2021121713225441600_CIT0032","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJM197505082921901","article-title":"Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon","volume":"292","author":"Gerich","year":"1975","journal-title":"N Engl J Med."},{"issue":"7","key":"2021121713225441600_CIT0033","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2337\/db09-1414","article-title":"The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action","volume":"59","author":"Hare","year":"2010","journal-title":"Diabetes."},{"issue":"8","key":"2021121713225441600_CIT0034","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1210\/en.2019-00398","article-title":"Localization of glucagon-like peptide-2 receptor expression in the mouse","volume":"160","author":"Yusta","year":"2019","journal-title":"Endocrinology."},{"key":"2021121713225441600_CIT0035","doi-asserted-by":"crossref","first-page":"e001025","DOI":"10.1136\/bmjdrc-2019-001025","article-title":"Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes","volume":"8(1)","author":"Lang","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2021121713225441600_CIT0036","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/dom.12958","article-title":"Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes","volume":"19(11)","author":"Guzman","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"2021121713225441600_CIT0037","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2337\/dci15-0033","article-title":"Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists","volume":"39","author":"Pearson","year":"2016","journal-title":"Diabetes Care."},{"issue":"11","key":"2021121713225441600_CIT0038","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1194\/jlr.M060897","article-title":"Glucagon receptor antagonism induces increased cholesterol absorption","volume":"56","author":"Guan","year":"2015","journal-title":"J Lipid Res."},{"issue":"7602","key":"2021121713225441600_CIT0039","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature17414","article-title":"Extra-helical binding site of a glucagon receptor antagonist","volume":"533","author":"Jazayeri","year":"2016","journal-title":"Nature."},{"issue":"12","key":"2021121713225441600_CIT0040","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gut.16.12.973","article-title":"Glucagon and the colon","volume":"16","author":"Taylor","year":"1975","journal-title":"Gut."},{"issue":"12","key":"2021121713225441600_CIT0041","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2337\/diabetes.49.12.2079","article-title":"Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes","volume":"49","author":"Parker","year":"2000","journal-title":"Diabetes."},{"issue":"3","key":"2021121713225441600_CIT0042","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI109717","article-title":"Glucagon deficiency and hyperaminoacidemia after total pancreatectomy","volume":"65","author":"Boden","year":"1980","journal-title":"J Clin Invest."},{"key":"2021121713225441600_CIT0043","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.3390\/ijms20215416","article-title":"Methods and Guidelines for Measurement of Glucagon in Plasma","volume":"20(21)","author":"Holst","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2021121713225441600_CIT0044","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/db18-0883","article-title":"Comparison of human and murine enteroendocrine cells by transcriptomic and peptidomic profiling","volume":"68","author":"Roberts","year":"2019","journal-title":"Diabetes."},{"key":"2021121713225441600_CIT0045","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.celrep.2019.01.047","article-title":"Important role of the GLP-1 Axis for glucose homeostasis after bariatric surgery","volume":"26(6)","author":"Larraufie","year":"2019","journal-title":"Cell Rep."},{"key":"2021121713225441600_CIT0046","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cmet.2018.10.003","article-title":"Dysregulation of glucagon secretion by hyperglycemia-induced sodium-dependent reduction of ATP production","volume":"29(2)","author":"Knudsen","year":"2019","journal-title":"Cell Metab"},{"issue":"1","key":"2021121713225441600_CIT0047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00441-014-1886-9","article-title":"Glucagon-like peptide 1 and peptide YY are in separate storage organelles in enteroendocrine cells","volume":"357","author":"Cho","year":"2014","journal-title":"Cell Tissue Res."},{"key":"2021121713225441600_CIT0048","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molmet.2018.07.011","article-title":"Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells","volume":"16","author":"Billing","year":"2018","journal-title":"Mol Metab."},{"issue":"4","key":"2021121713225441600_CIT0049","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/gutjnl-2014-306834","article-title":"Mechanisms of activation of mouse and human enteroendocrine cells by nutrients","volume":"64","author":"Symonds","year":"2015","journal-title":"Gut."},{"issue":"3","key":"2021121713225441600_CIT0050","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2015-3885","article-title":"Altered plasma levels of glucagon, GLP-1 and glicentin during OGTT in adolescents with obesity and type 2 diabetes","volume":"101","author":"Manell","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021121713225441600_CIT0051","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-4165(81)90222-1","article-title":"Effect of highly purified porcine gut glucagon-like immunoreactivity (glicentin) on glucose release from isolated rat hepatocytes","volume":"675","author":"Thieden","year":"1981","journal-title":"Biochim Biophys Acta."},{"issue":"6","key":"2021121713225441600_CIT0052","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/en.2013-2015","article-title":"Sweet taste receptors regulate basal insulin secretion and contribute to compensatory insulin hypersecretion during the development of diabetes in male mice","volume":"155","author":"Kyriazis","year":"2014","journal-title":"Endocrinology."},{"key":"2021121713225441600_CIT0053","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molmet.2018.03.004","article-title":"Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites","volume":"11","author":"Lund","year":"2018","journal-title":"Mol Metab."},{"issue":"7","key":"2021121713225441600_CIT0054","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00125-020-05158-9","article-title":"The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial","volume":"63","author":"Juel","year":"2020","journal-title":"Diabetologia."},{"issue":"11","key":"2021121713225441600_CIT0055","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1210\/en.2015-1301","article-title":"A Transcriptome-led exploration of molecular mechanisms regulating somatostatin-producing D-cells in the gastric epithelium","volume":"156","author":"Adriaenssens","year":"2015","journal-title":"Endocrinology."},{"key":"2021121713225441600_CIT0056","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab."},{"issue":"9","key":"2021121713225441600_CIT0057","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00125-017-4315-2","article-title":"The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice","volume":"60","author":"\u00d8rgaard","year":"2017","journal-title":"Diabetologia."},{"key":"2021121713225441600_CIT0058","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","article-title":"Insulin secretion depends on intra-islet glucagon signaling","volume":"25(5)","author":"Svendsen","year":"2018","journal-title":"Cell Rep"},{"issue":"4","key":"2021121713225441600_CIT0059","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2337\/db11-1605","article-title":"Liver-specific disruption of the murine glucagon receptor produces \u03b1-cell hyperplasia: evidence for a circulating \u03b1-cell growth factor","volume":"62","author":"Longuet","year":"2013","journal-title":"Diabetes."},{"issue":"23","key":"2021121713225441600_CIT0060","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1113\/jphysiol.2013.259796","article-title":"Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cells","volume":"591","author":"Raghupathi","year":"2013","journal-title":"J Physiol."},{"issue":"7","key":"2021121713225441600_CIT0061","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc15-1643","article-title":"Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies","volume":"39","author":"Kazda","year":"2016","journal-title":"Diabetes Care."},{"key":"2021121713225441600_CIT0062","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cell.2020.08.003","article-title":"The human and mouse enteric nervous system at single-cell resolution","volume":"182","author":"Drokhlyansky","year":"2020","journal-title":"Cell"},{"issue":"4","key":"2021121713225441600_CIT0063","doi-asserted-by":"crossref","first-page":"e0176031","DOI":"10.1371\/journal.pone.0176031","article-title":"Transcriptome of interstitial cells of Cajal reveals unique and selective gene signatures","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One."},{"issue":"8","key":"2021121713225441600_CIT0064","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/oby.2012.67","article-title":"The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin","volume":"20","author":"Kosinski","year":"2012","journal-title":"Obesity (Silver Spring)."},{"key":"2021121713225441600_CIT0065","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1136\/gutjnl-2019-319745","article-title":"Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease","volume":"69(12)","author":"Vily-Petit","year":"2020","journal-title":"Gut"},{"issue":"12","key":"2021121713225441600_CIT0066","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.2337\/db11-0571","article-title":"Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon","volume":"60","author":"Mutel","year":"2011","journal-title":"Diabetes."}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqab022\/36183918\/bqab022.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/162\/4\/bqab022\/41808468\/bqab022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/162\/4\/bqab022\/41808468\/bqab022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:42:16Z","timestamp":1639748536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqab022\/6127286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqab022","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,2,3]]},"article-number":"bqab022"}}